Connect with us

Research Reports

MEA Direct-to-Consumer Laboratory Testing Market Statistics, Demand and Forecasts to 2031

The Spirulina Extract Market’S Growth Is To Be Defined By Innovation Continuously

 

Middle East & Africa Direct-to-Consumer Laboratory Testing Market: Introduction

According to the report, the direct-to-consumer laboratory testing market in MEA was valued at US$ 124.40 Mn in 2020 and is projected to expand at a CAGR of 18.3% from 2021 to 2031. Direct-to-consumer laboratory testing, also known as direct access testing, allows patients to order tests directly from a lab without having to go through a healthcare professional. These test results can be used to track a current health condition, diagnose a previously undiagnosed medical condition, or provide information on personal health traits. 

In line with the rise in demand for quick, affordable, and accurate tests, several companies have considered offering actionable recommendations to complement the test results. This approach induces the customer to seek personalized services and maximizes customer satisfaction. This is anticipated to propel the market during the forecast period from 2021 to 2031.

Request Brochure of Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=83925

Rest of MEA held major share of the direct-to-consumer laboratory testing market in MEA in 2020, due to increase in government regulations, technological advancements, rise in awareness among people, and surge in the geriatric population.

Genetic Testing Dominated Middle East & Africa Direct-to-Consumer Laboratory Testing Market

In terms of test type, the direct-to-consumer laboratory testing market in MEA has been classified into genetic testing, disease risk assessment testing, CBC, chronic disease testing, COVID-19 testing, TSH testing, and others. The genetic testing segment has been split into nutrigenetics test, celiac disease test, sports & physical activity testing, men’s health tests, women’s health tests, pregnancy & prenatal screening, general health testing, and others. 

The nutrigenetics test sub-segment has been segregated into weight control, lactose intolerance, and others. The disease risk assessment testing segment has been classified into sexual health tests, cancer predisposition tests, and others. The sexual health tests sub-segment has been split into HIV, chlamydia, and others. The chronic disease testing segment has been split into diabetes testing, hypertension, and others. The genetic testing segment dominated the direct-to-consumer laboratory testing market in MEA in 2020, and the trend is projected to continue during the forecast period.

Request for Custom Research – https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=83925

Saliva Sample Type Held Major Market Share

Based on sample type, the direct-to-consumer laboratory testing market in MEA has been categorized into blood, saliva, urine, and others. The saliva segment held major share of the direct-to-consumer laboratory testing market in MEA in 2020.

Diagnostic Centers Emerge as Key Providers of Direct-to-Consumer Laboratory Tests

In terms of provider, the direct-to-consumer laboratory testing market in MEA has been divided into hospitals, clinics, specialty labs, and diagnostic centers. The diagnostic centers segment dominated the direct-to-consumer laboratory testing market in MEA during the forecast period.

Rest of MEA to Lead Market

In terms of country/sub-region, the direct-to-consumer laboratory testing market in MEA has been segmented into GCC Countries, South Africa, and Rest of MEA. Rest of MEA is anticipated to account for a leading share of the direct-to-consumer laboratory testing market in MEA during the forecast period.

Buy Middle East & Africa Direct-to-Consumer Laboratory Testing Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=83925&ltype=S

Growth Strategies of Key Players

Key players operating in the direct-to-consumer laboratory testing market in MEA are 23andMe, Inc., Ancestry, CircleDNA, Eurofins Scientific, Family Tree DNA (Gene by Gene), Laboratory Corporation of America Holdings, Living DNA Ltd., Medichecks.com Ltd., MyHeritage Ltd., MyMedLab, Inc., and Quest Diagnostics Incorporated. The direct-to-consumer laboratory testing market in MEA is consolidated with the presence of international and local players.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals. Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information, we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact Us

Mr. Rohit Bhisey

Transparency Market Research

USA – Canada Toll Free: 866-552-3453

Email: sales@transparencymarketresearch.com

Blog: https://tmrblog.com/

Follow UsTwitter | LinkedIn

Press Release Source: https://www.transparencymarketresearch.com/pressrelease/middle-east-africa-direct-to-consumer-laboratory-testing-market.htm

Continue Reading
Editorial & Advertiser disclosure

Recommended